Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (361-370 of 567) with videos related to

Pageof 57
Sort By:
The American Journal of Gastroenterology|August 12, 2010
Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurinesCarlos Teruel, Antonio López-San Román, Fernando Bermejo, et al.
Helicobacter|August 3, 2007
Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleedingJavier P Gisbert, Xavier Calvet, Faust Feu, et al.
Gastroenterology|April 9, 2013
Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistanceJavier Molina-Infante, Marco Romano, Miguel Fernandez-Bermejo, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 studySilvio Danese, Jean-Frederic Colombel, Milan Lukas, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 26, 2016
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based studyLaurent Peyrin-Biroulet, Gert Van Assche, Andreas Sturm, et al.
Inflammatory Bowel Diseases|January 25, 2013
Epidemiological risk factors in microscopic colitis: a prospective case-control studyFernando Fernández-Bañares, Monia R de Sousa, Antonio Salas, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2016
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort studyGert Van Assche, Laurent Peyrin-Biroulet, Andreas Sturm, et al.
European Journal of Gastroenterology & Hepatology|June 21, 2012
Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experienceYago González-Lama, Carlos Taxonera, Antonio López-Sanromán, et al.
Inflammatory Bowel Diseases|April 5, 2013
Impact of current smoking on the clinical course of microscopic colitisFernando Fernández-Bañares, Monia R de Sousa, Antonio Salas, et al.
GE Portuguese Journal of Gastroenterology|October 15, 2025
Effectiveness of First-Line Empirical Treatment in Portugal: Data from the European Registry on <i>Helicobacter pylori</i> ManagementMaria Inês Viegas, Miguel Areia, Luís Elvas, et al.
Pageof 57

Showing results (361-370 of 567) with videos related to

Sort By:
Pageof 57
The American Journal of Gastroenterology|August 12, 2010
Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurinesCarlos Teruel, Antonio López-San Román, Fernando Bermejo, et al.
Helicobacter|August 3, 2007
Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleedingJavier P Gisbert, Xavier Calvet, Faust Feu, et al.
Gastroenterology|April 9, 2013
Optimized nonbismuth quadruple therapies cure most patients with Helicobacter pylori infection in populations with high rates of antibiotic resistanceJavier Molina-Infante, Marco Romano, Miguel Fernandez-Bermejo, et al.
The Lancet. Gastroenterology & Hepatology|November 19, 2021
Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 studySilvio Danese, Jean-Frederic Colombel, Milan Lukas, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 26, 2016
Treatment satisfaction, preferences and perception gaps between patients and physicians in the ulcerative colitis CARES study: A real world-based studyLaurent Peyrin-Biroulet, Gert Van Assche, Andreas Sturm, et al.
Inflammatory Bowel Diseases|January 25, 2013
Epidemiological risk factors in microscopic colitis: a prospective case-control studyFernando Fernández-Bañares, Monia R de Sousa, Antonio Salas, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 4, 2016
Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months - Multicenter European cohort studyGert Van Assche, Laurent Peyrin-Biroulet, Andreas Sturm, et al.
European Journal of Gastroenterology & Hepatology|June 21, 2012
Methotrexate in inflammatory bowel disease: a multicenter retrospective study focused on long-term efficacy and safety. The Madrid experienceYago González-Lama, Carlos Taxonera, Antonio López-Sanromán, et al.
Inflammatory Bowel Diseases|April 5, 2013
Impact of current smoking on the clinical course of microscopic colitisFernando Fernández-Bañares, Monia R de Sousa, Antonio Salas, et al.
GE Portuguese Journal of Gastroenterology|October 15, 2025
Effectiveness of First-Line Empirical Treatment in Portugal: Data from the European Registry on <i>Helicobacter pylori</i> ManagementMaria Inês Viegas, Miguel Areia, Luís Elvas, et al.
Pageof 57